FourThought Financial’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $66K | Hold |
2,453
| – | – | 0.01% | 527 |
|
|
2022
Q2 | $34K | Buy |
2,453
+422
| +21% | +$5.85K | 0.01% | 728 |
|
|
2022
Q1 | $40K | Buy |
2,031
+269
| +15% | +$5.3K | 0.01% | 733 |
|
|
2021
Q4 | $29K | Sell |
1,762
-274
| -13% | -$4.51K | ﹤0.01% | 833 |
|
|
2021
Q3 | $56K | Buy |
2,036
+17
| +0.8% | +$468 | 0.01% | 657 |
|
|
2021
Q2 | $59K | Buy |
2,019
+79
| +4% | +$2.31K | 0.01% | 656 |
|
|
2021
Q1 | $54K | Sell |
1,940
-284
| -13% | -$7.91K | 0.01% | 672 |
|
|
2020
Q4 | $63K | Buy |
+2,224
| New | +$63K | 0.01% | 610 |
|